Accountable Healthcare - Measles Management and Prevention: Key Strategies for Healthcare Professionals
Skip to Main Content Skip to Menu Skip to Footer
May 3, 2024

Measles Management and Prevention: Key Strategies for Healthcare Professionals

Measles is a highly contagious respiratory virus that causes febrile rash illness. Measles has been eliminated (with no sustained circulation) in the United States for decades. However, there can still be measles cases, as it is easily imported by unvaccinated travelers and can spread in under-immunized communities.

Disease Course

The incubation period is typically 11–12 days from exposure to the measles virus until the first symptoms appear (prodromal symptoms). A rash follows the prodromal symptoms 2–4 days later and usually lasts 5–6 days. Measles is infectious 4 days before and 4 days after rash onset.

Symptoms

Prodromal: Fever, cough, coryza, or conjunctivitis. Koplik spots (tiny white spots inside the mouth) may also appear 2–3 days after symptoms first appear.
Rash: A maculopapular rash (rash of both flat and raised skin lesions) begins on the head and face and then spreads downward to the neck, trunk, arms, legs, and feet. The spots may become joined together as they spread from the head to the body. Fever may spike to more than 104° F when a rash appears.

Complications

Most common complications: Diarrhea and otitis media.

Most severe complications: Pneumonia, encephalitis, and death. Patients may require hospitalization. Children younger than 5, adults older than 20, pregnant women, and immunocompromised persons are at most risk of serious complications.

What to do if you have a suspected case

  1. Immediately mask and isolate the patient in a room with a closed door (negative pressure room if available). Follow standard and airborne precautions.
  2. Only allow health care workers with presumptive evidence of measles immunity* to attend the patient; they must use N-95 masks.
  3. Evaluate the patient and order measles confirmatory testing (collect a throat or nasopharyngeal swab for RT-PCR and serum for IgM measles testing).
  4. Contact infection control if available at your facility. Immediately report this suspected case to your local and/or state health department.

For questions regarding specimen collection, storage, and shipment, please visit https://www.cdc.gov/measles/labtools/rt-pcr.html

Resources:
Measles information for healthcare providers: https://www.cdc.gov/measles/hcp/index.html
Measles vaccine recommendations: https://www.cdc.gov/measles/vaccination.html
Infection control guidelines for measles: https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html
Surveillance manual chapter on measles: https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html


*Presumptive evidence of measles immunity for healthcare workers (one of the following): documentation of two doses of measles-containing vaccine, laboratory evidence of immunity (positive IgG), laboratory evidence of disease, or birth before 1957. Self-reported doses and a history of vaccination provided by a parent or other caregiver, or a clinical diagnosis of measles, should not be accepted.